Specialty pharmacy profit pools are still growing ... beating its benchmark by 218 percentage points (see more details here). United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology ...

United Therapeutics Corporation (NASDAQ ... and again what is normally a seasonally weak fourth quarter for specialty pharmacy ordering. In the fourth quarter, we saw record patient shipments ...

A discussion on Texas' cannabis industry, medical marijuana and legislative hurdles. for insights into regulation, patient ...

Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics Year End 2024 Financial ... by commercial launch activities in the United States, with products anticipated to be available ...

Vertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, ...

It is meant to be a collective issue for all," he said, emphasizing that a united effort is essential to bringing about ...

Impaired lysosomal function (breaking down waste) leads to accumulation of excess lipids in liver cells, worsening NAFLD and contributing to its progression. By analyzing a clinical gene-profiling ...

Journavx has been placed on Tier 3 of Optum Rx Premium and Select Formularies and is being further evaluated by the Optum Rx National Pharmacy & Therapeutics Committee for clinical value and safety.

Thank you for standing by, and welcome to Corcept Therapeutics conference call ... or GOG, in the United States and the European network of Gynecologic Oncology Trials or ENGOT Group in Europe ...